These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34213063)

  • 1. N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability.
    Ferlenghi F; Mari M; Gobbi G; Elisi GM; Mor M; Rivara S; Vacondio F; Bartolucci S; Bedini A; Fanini F; Spadoni G
    ChemMedChem; 2021 Oct; 16(19):3071-3082. PubMed ID: 34213063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
    Rivara S; Vacondio F; Fioni A; Silva C; Carmi C; Mor M; Lucini V; Pannacci M; Caronno A; Scaglione F; Gobbi G; Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G
    ChemMedChem; 2009 Oct; 4(10):1746-55. PubMed ID: 19728346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
    Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
    J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT
    Mari M; Elisi GM; Bedini A; Lucarini S; Retini M; Lucini V; Scaglione F; Vincenzi F; Varani K; Castelli R; Mor M; Rivara S; Spadoni G
    Eur J Med Chem; 2022 Dec; 243():114762. PubMed ID: 36150258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria.
    Elisi GM; Bedini A; Scalvini L; Carmi C; Bartolucci S; Lucini V; Scaglione F; Mor M; Rivara S; Spadoni G
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32899888
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).
    Ettaoussi M; Pérès B; Errazani A; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2015 Jan; 90():822-33. PubMed ID: 25528336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.
    Bolteau R; Descamps F; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
    Eur J Med Chem; 2020 Mar; 189():112078. PubMed ID: 32004937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
    López-Canul M; Comai S; Domínguez-López S; Granados-Soto V; Gobbi G
    Eur J Pharmacol; 2015 Oct; 764():424-432. PubMed ID: 26162699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of the ligand binding and signaling mechanism of melatonin receptors.
    Wang Q; Lu Q; Guo Q; Teng M; Gong Q; Li X; Du Y; Liu Z; Tao Y
    Nat Commun; 2022 Jan; 13(1):454. PubMed ID: 35075127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
    de la Fuente Revenga M; Herrera-Arozamena C; Fernández-Sáez N; Barco G; García-Orue I; Sugden D; Rivara S; Rodríguez-Franco MI
    Eur J Med Chem; 2015 Oct; 103():370-3. PubMed ID: 26367450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
    Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways.
    Lopez-Canul M; Palazzo E; Dominguez-Lopez S; Luongo L; Lacoste B; Comai S; Angeloni D; Fraschini F; Boccella S; Spadoni G; Bedini A; Tarzia G; Maione S; Granados-Soto V; Gobbi G
    Pain; 2015 Feb; 156(2):305-317. PubMed ID: 25599452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
    Hu Y; Chan KH; He X; Ho MK; Wong YH
    PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology models of melatonin receptors: challenges and recent advances.
    Pala D; Lodola A; Bedini A; Spadoni G; Rivara S
    Int J Mol Sci; 2013 Apr; 14(4):8093-121. PubMed ID: 23584026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin receptor ligands: A pharmaco-chemical perspective.
    Boutin JA; Witt-Enderby PA; Sotriffer C; Zlotos DP
    J Pineal Res; 2020 Oct; 69(3):e12672. PubMed ID: 32531076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of ligand recognition at the human MT
    Stauch B; Johansson LC; McCorvy JD; Patel N; Han GW; Huang XP; Gati C; Batyuk A; Slocum ST; Ishchenko A; Brehm W; White TA; Michaelian N; Madsen C; Zhu L; Grant TD; Grandner JM; Shiriaeva A; Olsen RHJ; Tribo AR; Yous S; Stevens RC; Weierstall U; Katritch V; Roth BL; Liu W; Cherezov V
    Nature; 2019 May; 569(7755):284-288. PubMed ID: 31019306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.
    Párraga J; Moreno L; Diaz A; El Aouad N; Galán A; Sanz MJ; Caignard DH; Figadère B; Cabedo N; Cortes D
    Eur J Med Chem; 2014 Oct; 86():700-9. PubMed ID: 25232966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
    Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
    J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
    J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.